Drugs / CJCV1
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02067676 | Apr → Sep 2014 | campylobacteriosis | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CJCV1 | “Capsule-Conjugate Campylobacter Vaccine (CJCV1)” NCT02067676 ↗ |
| Known as | Capsule-Conjugate Campylobacter Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02067676 ↗ |
| Modality | Vaccine | “potential vaccine against Campylobacter” NCT02067676 ↗ |
| Route | Intramuscular | “with an intramuscular dose of Capsule-Conjugate Campylobacter Vaccine (CJCV1) equivalent to 2 μg of polysaccharide” NCT02067676 ↗ |